Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
61,381,279
-
Shares change
-
+6,172,542
-
Total reported value, excl. options
-
$273,753,545
-
Value change
-
+$25,683,517
-
Put/Call ratio
-
110%
-
Number of buys
-
71
-
Number of sells
-
-61
-
Price
-
$4.46
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2021
190 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q3 2021.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,381,279 shares
.
Largest 10 shareholders include STATE STREET CORP (14,674,754 shares), VANGUARD GROUP INC (12,294,891 shares), BlackRock Inc. (9,495,073 shares), Palo Alto Investors LP (4,484,411 shares), GEODE CAPITAL MANAGEMENT, LLC (2,020,571 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,250,983 shares), NORTHERN TRUST CORP (1,127,648 shares), Ikarian Capital, LLC (1,112,669 shares), MORGAN STANLEY (1,035,594 shares), and UBS Group AG (947,503 shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.